Thyroid cancer cell line

Show results for

Unknown (364)
Transcriptomics (226)
Genomics (124)
Proteomics (17)
Clinical (4)
Other (3)
Metabolomics (3)

Organisms

Homo sapiens (211)
Mus musculus (38)
Andropogon gerardi (12)
Bacteria (12)
Canis lupus familiaris (12)
Clavibacter nebraskensis NCPPB 2581 (12)
Cnidaria (12)
Ensifer adhaerens (12)
Fasciola (12)
Human alphaherpesvirus 1 strain 17 (12)
Human alphaherpesvirus 1 strain KOS (12)
Human betaherpesvirus 5 (12)
Human herpesvirus 2 strain 186 (12)
Mesocricetus auratus (12)
Miscanthus x giganteus (12)
Mus musculus (12)
Panicum virgatum (12)
Platyhelminthes (12)
Pseudomonas aeruginosa PA103 (12)
Rattus norvegicus (12)
Rattus rattus (12)
Rhodococcus jostii RHA1 (12)
Rattus norvegicus (5)
Drosophila melanogaster (4)
Legionella pneumophila subsp. pneumophila str. Philadelphia 1 (1)
Leishmania major (1)
Schizosaccharomyces pombe (1)
Caenorhabditis elegans (1)
Danio rerio (1)
Cordyceps militaris (1)

Organisms

Homo sapiens (67)
Mus musculus (5)
Rattus norvegicus (2)

Repository

biostudies-arrayexpress (214)
ENA (90)
geo (43)
pride (12)
EGA (7)
MassIVE (5)
ExpressionAtlas (2)
MetaboLights (2)
iProX (1)
MetabolomicsWorkbench (1)

Tissue

Thyroid gland (4)
Cell culture (4)
Adrenal gland (1)
Bile duct (1)
Bone (1)
Brain (1)
Breast (1)
Connective tissue (1)
Esophagus (1)
Gall bladder (1)
Hematopoietic system (1)
Kidney (1)
Large intestine (1)
Liver (1)
Lung (1)
Mucosa (1)
Musculature (1)
Ovary (1)
Pancreas (1)
Peripheral nervous system (1)
Placenta (1)
Prostate gland (1)
Skin (1)
Stomach (1)
Testis (1)
Urinary bladder (1)
Uterine cervix (1)
Uterus (1)
Vulva (1)
Cultured cells (1)

Disease

Head and neck squamous cell carcinoma (3)
Acute myeloid leukemia (2)
Adrenal gland neuroblastoma (2)
Anaplastic astrocytoma (2)
Askin tumor (2)
B-cell acute lymphoblastic leukemia (2)
Bladder carcinoma (2)
Bladder transitional cell carcinoma (2)
Breast adenocarcinoma (2)
Breast carcinoma (2)
Burkitts lymphoma (2)
Cervical squamous cell carcinoma (2)
Cholangiocarcinoma (2)
Chondrosarcoma (2)
Chronic myelogenous leukemia (2)
Clear cell renal carcinoma (2)
Colorectal carcinoma (2)
Cutaneous T-cell lymphoma (2)
Diffuse large B-cell lymphoma (2)
Esophageal adenocarcinoma (2)
Esophageal squamous cell carcinoma (2)
Ewing sarcoma (2)
Fibrosarcoma (2)
Follicular thyroid carcinoma (2)
Gastric adenocarcinoma (2)
Hepatocellular carcinoma (2)
Hodgkins lymphoma (2)
Invasive ductal carcinoma (2)
Invasive lobular carcinoma (2)
Large cell lung carcinoma (2)

Technology Type

Mass Spectrometry (13)
Shotgun proteomics (6)
Mass spectrometry (2)
Bottom-up proteomics (2)
Illumina HiSeq 2500, Illumina MiSeq (1)
Illumina HiSeq 2500, Illumina HiSeq 2000 (1)
ESI (1)
Affinity purification coupled with mass spectrometry proteomics (1)
Data-dependent acquisition (1)
Data-independent acquisition (1)
Gel-based experiment (1)
SWATH MS (1)
Top-down proteomics (1)

Instrument Platform

NextSeq 500 (15)
Illumina NovaSeq 6000 (13)
LTQ Orbitrap Elite (3)
Illumina HiSeq 2500 (2)
Illumina HiSeq 2000 (2)
Illumina HiSeq 4000 (2)
Q Exactive (2)
Sequel II (1)
Linux server, HPC cluster (1)
Not applicable in this study (1)
Thermal cycler (Bio-Rad C1000), Agilent 2100 Bioanalyzer, Qubit 4 Fluorometer (1)
Benchtop centrifuge, vortex, NanoDrop or plate reader (for RiboGreen assay), TapeStation (Agilent) (1)
Liquid nitrogen freezer, surgical instruments (1)
PromethION (1)
Covaris (1)
Qubit (1)
G2565AA DNA microarray scanner [Agilent] (1)
GenePix 4000B [Axon Instruments] (1)
NextSeq 2000 (1)
Orbitrap Fusion (1)
TripleTOF 5600 (1)
Liquid Chromatography MS (1)

Publication Date

2011 (31)
2014 (26)
2012 (26)
2015 (24)
2009 (19)
2025 (18)
2013 (16)
2023 (15)
2016 (13)
2010 (13)
2008 (13)
2024 (12)
2026 (9)
2021 (8)
2022 (7)
2019 (7)
2020 (5)
2017 (4)
2018 (4)
2007 (2)
2006 (2)
2005 (2)
2004 (1)
2003 (1)

CHEBI ID

CHEBI:46550 (1)
CHEBI:197435 (1)
CHEBI:197436 (1)
CHEBI:136461 (1)
CHEBI:31991 (1)
CHEBI:133523 (1)
CHEBI:165827 (1)
CHEBI:165824 (1)
CHEBI:15245 (1)
CHEBI:133693 (1)
CHEBI:133677 (1)
CHEBI:133672 (1)
CHEBI:84562 (1)
CHEBI:84814 (1)
CHEBI:78266 (1)
CHEBI:78268 (1)
CHEBI:74532 (1)
CHEBI:132188 (1)
CHEBI:133144 (1)
CHEBI:133141 (1)
CHEBI:133139 (1)
CHEBI:75038 (1)
CHEBI:133515 (1)
CHEBI:30413 (1)
CHEBI:84056 (1)
CHEBI:133733 (1)
CHEBI:26073 (1)
CHEBI:132966 (1)
CHEBI:37684 (1)
CHEBI:73000 (1)

Metabolite Name

Decaethylenglycol (1)
Alpha-PBP (1)
N-Methylnicotinamide 13C-Isotope (1)
Thymidine 5'-monophosphate (1)
Sulfate (1)
Sphingadienine (1)
Ribulose/xylulose 5-phosphate (1)
Pyroglutamine (1)
Phenol red (1)
Penicillin G (1)
Palmitoyl dihydrosphingomyelin (d18:0/16:0) (1)
Glycerophosphoserine (1)
Glycerophosphoinositol (1)
Glucuronate 1-phosphate (1)
Gamma-glutamylisoleucine (1)
Erythronate (1)
Cysteine sulfinic acid (1)
Behenoyl sphingomyelin (d18:1/22:0) (1)
Alpha-ketoglutaramate (1)
2-stearoyl-GPE (18:0) (1)
2-palmitoleoyl-GPC (16:1) (1)
1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) (1)
1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6) (1)
1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) (1)
1-oleoyl-2-linoleoyl-GPE (18:1/18:2) (1)
1-oleoyl-2-linoleoyl-GPC (18:1/18:2) (1)
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6) (1)
1-arachidonoyl-GPI (20:4) (1)
1-(1-enyl-stearoyl)-GPE (P-18:0) (1)
1-(1-enyl-palmitoyl)-GPE (P-16:0) (1)

First Public Date

2024 (14)
2025 (12)
2023 (10)
2014 (10)
2026 (7)
2022 (6)
2020 (6)
2017 (6)
2019 (4)
2018 (4)
2016 (4)
2015 (4)
2021 (3)

Study status

Completed (2)
Active, not recruiting (1)
Recruiting (1)

Study type

Transcription profiling by array (125)
RNA-seq of coding RNA (37)
ChIP-seq (17)
Comparative genomic hybridization by array (5)
RNA-seq of non coding RNA (4)
Interventional (4)
Unknown experiment type (3)
Methylation profiling by array (3)
Cell line - High-throughput sequencing (2)
ChIP-chip by array (2)
RNA-seq of total RNA (2)
ChIP-chip by tiling array (1)
Cell line - One-color microarray (1)
RNAi profiling by array (1)
MBD-seq (1)
ATAC-seq (1)
Ribo-seq (1)
Other (1)
DNA-seq (1)
RNA-seq of coding RNA from single cells (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2015 (43)
2021 (42)
2023 (41)
2025 (39)
2020 (37)
2024 (36)
2022 (36)
2014 (34)
2018 (33)
2019 (32)
2011 (32)
2012 (31)
2016 (28)
2013 (22)
2017 (20)
2009 (20)
2010 (17)
2008 (16)
2026 (7)
2006 (4)
2007 (3)
2005 (2)
2004 (1)
2003 (1)
1998 (1)

Lab affiliation

Affiliated Hangzhou First People’s Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, Westlake University, Hangzhou, Zhejiang Province, China. Westlake Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang Province, China. Research Center for Industries of the Future, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China. (1)
Bavarian Center for Biomolecular Mass Spectrometry Technische Universität München Gregor-Mendel-Straße 4 85354 Freising GERMANY (1)
CNIO (1)
Department of Genetics, Stanford University (1)
Department of Medicine (GI Oncology), UCSF, United States (1)
Drug Discovery Moffitt Cancer Center Tampa, FL, USA (1)
Graduate Institute of Biomedical Sciences, department of Cell and Molecular Biology, College of Medicine, and Molecular Medicine Research Center, Chang Gung University, Taoyuan 33302, Taiwan. Liver Research Center, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan 33302, Taiwan. (1)
Instituto de Investigaciones Sanitarias de Santiago de Compostela (1)
Macquarie University Australian Proteome Analysis Facility (APAF) Sydney, Australia (1)
Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35042 Rennes, France (1)
West China Hospital, Sichuan University (1)
università degli studi di Milano, medicina veterinaria, DIMEVET (1)

Location

United States (4)
Norway (2)
Denmark (2)
Germany (2)
Italy (2)
Spain (2)
Canada (2)
Netherlands (2)
France (2)
Austria (2)
Guam (1)
Finland (1)
Ireland (1)
North Korea (1)
Asia except Japan (1)
Europe (1)
North America (1)
Puerto Rico (1)
Turkey (1)
Russia (1)
China (1)
Poland (1)
Belgium (1)
Brazil (1)
United Kingdom (1)
Sweden (1)
Japan (1)
Switzerland (1)
South Korea (1)

Keyword

Dabrafenib (2)
Trametinib (2)
Antibodies (2)
Tafinlar (1)
Anaplastic thyroid cancer (ATC) (1)
Biliary tract cancer (BTC) (1)
Low grade (WHO G1/G2) glioma (LGG) (1)
High grade (WHO G3/G4) glioma (HGG) (1)
Non-seminomatous germ cell tumors (NSGCT)/non-germinomatous germ cell tumors (NGGCT) (1)
Adenocarcinoma of the small intestine (ASI) (1)
Hairy cell leukemia (HCL) (1)
Gastrointestinal stromal tumor (GIST) (1)
BRAF V600E mutation (1)
Cholangiocarcinoma (1)
Osimertinib (1)
Ipatasertib (1)
GSK2636771 (1)
Adavosertib (1)
Immunoconjugates (1)
Afatinib (1)
Crizotinib (1)
Multiple myeloma (MM) (1)
Safety (1)
Palbociclib (1)
Trastuzumab biosimilar HLX02 (1)
Dasatinib (1)
Atezolizumab (1)
Ado-Trastuzumab Emtansine (1)
Maytansine (1)
Relatlimab (1)

Previous page
1 / 75
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 75
Next page

Sort by:

Relevance

Page size

Cancer Cell Line Encyclopedia Metabolomics

Not available

ORGANISM(S): Homo sapiens

ST001142 | MetabolomicsWorkbench

Shotgun proteomics of thyroid carcinoma exosomes: insight into the role of exosomal proteins in carcinogenesis and thyroid homeostasis

The transport of molecules via exosomes is one of the factors involved in cancer development, and transferred molecules can serve as specific tumor biomarkers. The aim of the study was the LC MS/MS proteomic analysis of exosomes released by FTC and 8305C thyroid cancer cell lines, and reference Nthy...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2023-10-19 | MSV000093152 | MassIVE

Transcription profiling of micro-RNA genes in human papillary thyroid carcinoma

We show that numerous miRNAs are transcriptionally up-regulated in papillary thyroid carcinoma (PTC) tumors compared with unaffected thyroid tissue. Among the predicted target genes of the three most upregulated miRNAs (miRs 221, 222 and 146b), only less than 15% showed significant downexpression i...

ORGANISM(S): Homo sapiens

2007-09-01 | E-GEOD-3467 | biostudies-arrayexpress

Human thyroid cell line complex CF-DIA-MS

This project aims to explore the protein interaction network of thyroid cancer cell lines through a robotics platform combined with proteomic techniques. The primary method involves using CF-DIA-MS (Co-fractionation Data-Independent Acquisition Mass Spectrometry) to acquire data from three different...

ORGANISM(S): Homo sapiens (Human)

2025-12-20 | PXD059608 | Pride

ChIP-seq analysis against E2F7 in CAL62 anaplastic thyroid cancer cells

ChIP-seq experiment was performed using an antibody against E2F7 in CAL62 anaplastic thyroid cancer cell line, in order to define the genomic regions bound by this transcription factor and exploit its genomic function in this cancer setting.

ORGANISM(S): Homo sapiens

2023-02-07 | E-MTAB-12277 | biostudies-arrayexpress

Gene expression profiling of human anaplastic thyroid carcinoma cells by microarray

In this study, we profiled the change of gene expression by p53 knock-down on anaplastic thyroid carcinoma (ATC) cell line, KAT-18 cells using Applied Biosystem's Microarrays. When compared with the untreated control KAT-18 cells, 2,926 genes were found to have altered expression levels of 2-fold or...

ORGANISM(S): Homo sapiens

2010-06-25 | E-GEOD-12912 | biostudies-arrayexpress

Transcriptional profile changes by Prox1 expression in thyroid cancer cells

Human thyroid cancer cell line BCPAP was engineered for doxycyclin-mediated inducible expressoin of Prox1 and next generation sequcing was performed to study the transcriptional regulation by Prox1 BCPAP cells were infected with rTTA2 lentivirus. The resulting cell populations were then stably trans...

ORGANISM(S): Homo sapiens

2016-03-02 | E-GEOD-75059 | biostudies-arrayexpress

LC-MS/MS analysis of human thyroid cystic fluid and thyroid cancer cell secreted proteins

Thyroid ultrasound and ultrasound-guided fine-needle aspiration (USG/FNA) biopsy are currently used for diagnosing papillary thyroid carcinoma (PTC), but their detection limit could be improved by combining other biomarkers. To discover novel PTC biomarkers, we herein applied a GeLC-MS/MS strategy t...

ORGANISM(S): Homo sapiens (Human)

2018-03-21 | PXD007532 | Pride

Human Thyroid cystic fluid Thyroid cancer cell Lc-ms/ms

Genome Haploidisation with Chromosome 7 Retention in Oncocytic Follicular Thyroid Carcinoma

Recurrent non-medullary thyroid carcinoma (NMTC) is a rare disease. We initially characterized 27 recurrent NMTC: 13 papillary thyroid cancers (PTC), 10 oncocytic follicular carcinomas (FTC-OV), and 4 non-oncocytic follicular carcinomas (FTC). A validation cohort composed of benign and malignant (bo...

ORGANISM(S): Homo sapiens

2012-08-29 | E-GEOD-31828 | biostudies-arrayexpress

DIFFERENTIAL GENE EXPRESSION OF MEDULLARY THYROID CARCINOMA REVEALS SPECIFIC MARKERS ASSOCIATED WITH GENETIC CONDITIONS.

Transcriptional analysis of 49 primary medullary thyroid carcinoma tumors. Comparisons MTCM918T vs MTC634 and MTCM918T vs MTCWT. 49 (52 hybridized tumors with 3 replicates) primary Medullary Thyroid Carcinoma (MTC) cases were hybridized onto a cDNA microarray in order to identify the unique markers ...

ORGANISM(S): Homo sapiens

2013-11-26 | E-GEOD-32662 | biostudies-arrayexpress

Previous page
1 / 75
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 75
Next page

Sort by:

Relevance

Page size

745 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Study status

Study type

Release Date

Lab affiliation

Location

Tags

Keyword

OmicsDI is part of the ELIXIR infrastructure

Tweets